|
C5ORF41 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.15369999997839E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.09580000523724E-08 |
| Normal-vs-Stage2 |
1.630420E-02 |
| Normal-vs-Stage3 |
4.099300E-03 |
| Normal-vs-Stage4 |
1.448170E-01 |
| Stage1-vs-Stage2 |
2.865000E-01 |
| Stage1-vs-Stage3 |
4.932400E-01 |
| Stage1-vs-Stage4 |
5.534000E-01 |
| Stage2-vs-Stage3 |
7.240400E-01 |
| Stage2-vs-Stage4 |
8.884200E-01 |
| Stage3-vs-Stage4 |
9.078200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95170000050204E-07 |
| Normal-vs-AfricanAmerican |
6.22970000030421E-07 |
| Normal-vs-Asian |
2.095700E-03 |
| Caucasian-vs-AfricanAmerican |
6.674600E-01 |
| Caucasian-vs-Asian |
6.678000E-01 |
| AfricanAmerican-vs-Asian |
7.375000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.37579999615056E-08 |
| Normal-vs-Female |
2.798900E-03 |
| Male-vs-Female |
2.013600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.186800E-04 |
| Normal-vs-Extreme_Weight |
6.67230004580688E-09 |
| Normal-vs-Obese |
1.555540E-03 |
| Normal-vs-Extreme_Obese |
4.02200000000352E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.813800E-01 |
| Normal_Weight-vs-Obese |
2.928800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.331000E-01 |
| Extreme_Weight-vs-Obese |
7.857800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.421400E-01 |
| Obese-vs-Extreme_Obese |
1.806400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.606300E-04 |
| Normal-vs-Age(41-60Yrs) |
2.193200E-04 |
| Normal-vs-Age(61-80Yrs) |
4.71369998589211E-09 |
| Normal-vs-Age(81-100Yrs) |
1.57087000000056E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.297200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.273000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.443400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.619640E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.156500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.502600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.91070004052341E-09 |
| Normal-VS-Type2 PRCC |
3.622600E-04 |
| Normal-VS-KIRP CIMP |
3.699100E-03 |
| Normal-VS-Unclassified PRCC |
1.222590E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.508100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.579600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.900100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.430600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.342800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.286200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.99699999980929E-07 |
| Normal-vs-N1 |
9.398800E-03 |
| Normal-vs-N2 |
1.962430E-02 |
| N0-vs-N1 |
1.788200E-01 |
| N0-vs-N2 |
8.745800E-01 |
| N1-vs-N2 |
6.774800E-01 |
|
|
